EUVIMEDEUVIMED entdecken
Open Access · CC BYNC 4.0

Development of the Korean High-Alert Medication Stratification Tool (K-HAMST)

Ahyoung Lee, Ji Min Han, Kwanghee Jun, Kyu Nam Heo, McKenzie S. Grinalds, Natalie C. Washburn, Todd A. Walroth, Young-Mi Ah, Ju-Yeun Lee

Research in Clinical Pharmacy · 2023

DOI: 10.59931/rcp.23.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2023. Verfasst von Ahyoung Lee und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health & Welfare.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is no objective and standardized tool for stratification of high-alert medications (HAMs) that reflect each institution's practice of medication management, drug utilization in the institution, and patient safety protocols in the Korean hospital settings.We aimed to develop the Korean version of the high-alert medication stratification tool (K-HAMST) and assess its content validity and reliability.

Methods

Ten clinical pharmacists from multi-site hospitals completed a two-round Delphi survey to assess the content validity of the translated High-Alert Medication Stratification Tool-Revised.Content validity was demonstrated using the item content validity index and scale content validity index (S-CVI).An expert meeting was conducted to revise the tool to accommodate the clinical practice and workflow in Korea based on the results of the content validity index.Reliability was assessed by calculating the risk scores for 37 HAMs and 37 control medications.The interrater reliability of each medication was assessed using the Kendall's coefficient of concordance (W).

Results

The initial S-CVI was 0.71.After revision, the final S-CVI of the K-HAMST was 0.92, indicating that the tool has content validity.The HAM scores ranged from 3 to 8 (n=37; median [interquartile {IQR},[4][5]), whereas the control medication scores ranged from 1 to 2 (n=37; median [IQR], 1 [1-1]).The Kendall's coefficient of concordance (W) was 0.57, indicating moderate agreement between raters (p

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health & Welfare

Zitieren

APA

Lee, A., Han, J. M., Jun, K., Heo, K. N., Grinalds, M. S., Washburn, N. C., Walroth, T. A., Ah, Y., & Lee, J. (2023). Development of the Korean High-Alert Medication Stratification Tool (K-HAMST). Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.23.005

Vancouver

Lee A, Han JM, Jun K, Heo KN, Grinalds MS, Washburn NC, et al. Development of the Korean High-Alert Medication Stratification Tool (K-HAMST). Research in Clinical Pharmacy. 2023. doi:10.59931/rcp.23.005

BibTeX
@article{Lee2023,
  author = {Lee, Ahyoung and Han, Ji Min and Jun, Kwanghee and Heo, Kyu Nam and Grinalds, McKenzie S. and Washburn, Natalie C. and Walroth, Todd A. and Ah, Young-Mi and Lee, Ju-Yeun},
  title = {Development of the Korean High-Alert Medication Stratification Tool (K-HAMST)},
  journal = {Research in Clinical Pharmacy},
  year = {2023},
  doi = {10.59931/rcp.23.005}
}
Kostenlos starten →